HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.
ICC 2019

Rossana Berardi

Rossana Berardi, Speaker at  Cancer Congress
Universita Politecnica delle Marche, Italy
Title : Dept of medical oncology in Ancona: A new model of integrated care pathways for a multidisciplinary management for cancer patients


I n recent years, thanks to scientific research, the therapeutic options for cancer patients have significantly increased with a significant improvement in prognosis. In addition, the outcome of cancer patients improves if they are treated in centers of reference with high volumes of users and that offer access to clinical trials. Several scientific evidences have shown that the correct management of the cancer patient requires an integrated multidisciplinary approach, which allows improving and speeding up the diagnostic-therapeutic approach. The Dept of Medical Oncology of Ancona is the reference regional cancer center for the entire region and neighboring territories. In order to improve the management of cancer patients, it offers innovative and various integrated care pathways (ICP) involving numerous specialists for a multidisciplinary management of diagnostic and therapeutic iter of cancer patients (among the others, the Breast cancer unit, involving breast cancer surgeons, radiotherapists, radiologists, physiotherapists and oncologists). Ospedali Riuniti of Ancona is the first and only in Italy to have achieved a certification for cancer ICPs, which are enriched with the genetic cancer center and with the GCP trials center, conducting numerous clinical trials including early stage trials (phase I) and offering patients numerous innovative therapies, that are both belong to Dept of Medical Oncology. Furthermore, along with the best and innovative oncologic therapies, the Dept focuses on psychological and social aspect of cancer patients, offering a range of social activities to support cancer patients and caregivers. This innovative approach is the winning key to ameliorate the management of cancer patients and improving their prognosis and the description of this new model will be the object of the presentation.


Rossana Berardi, MD, Director of Department of Medical Oncology, Director of the Postgraduate School of Oncology, Head of “Genetic Cancer” Laboratory, Deputy Director of Department of Clinical and Molecular Science and coordinator of the Hospital Breast Unit at Università Politecnica of Marche Region – Ospedali Riuniti of Ancona, Italy. She is author of more than 200 manuscripts in peer-reviewed journals and of more than 100 abstracts, speaker at national and international meetings and involved in advisory boards expecially chest tumours, neuroendocrine tumours, SIADH and on clinical and translational research.